Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Biosciences Laboratory
Francesco Fabbri has not added Biography.
If you are Francesco Fabbri and would like to personalize this page please email our Author Liaison for assistance.
Circulating Tumor Cells: Back to the Future.
Frontiers in oncology , 2016 | Pubmed ID: 28123996
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.
Cancer letters Jul, 2013 | Pubmed ID: 23419522
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.
Annals of translational medicine Nov, 2014 | Pubmed ID: 25489583
Epithelial Mesenchymal Transition: a double-edged sword.
Clinical and translational medicine , 2015 | Pubmed ID: 25932287
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
Journal of translational medicine Jul, 2015 | Pubmed ID: 26174551
Circulating tumor cells in early breast cancer: A connection with vascular invasion.
Cancer letters Oct, 2015 | Pubmed ID: 26184997
CTCs in early breast cancer: A path worth taking.
Cancer letters Jul, 2016 | Pubmed ID: 27060205
Circulating Tumor Cells in the Adenocarcinoma of the Esophagus.
International journal of molecular sciences Aug, 2016 | Pubmed ID: 27527155
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Oncotarget Jan, 2017 | Pubmed ID: 27911856
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
Cancer chemotherapy and pharmacology May, 2017 | Pubmed ID: 28341957
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.
OncoTargets and therapy , 2017 | Pubmed ID: 29033584
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Giulia Gallerani1,
Claudia Cocchi2,
Martine Bocchini3,
Filippo Piccinini1,
Francesco Fabbri1
1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
2, Associazione Annastaccatolisa Onlus,
3Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved